Risk of death following acute coronary syndromes different for men, womenAugust 26, 2009Women may have a slightly higher risk of death than men in the 30 days following an acute coronary syndrome (ACS; such as heart attack or unstable angina), but this difference appears attributable to factors such as severity and type of ACS, clinical differences and angiographic severity according to a study in the August 26 issue of JAMA. "Cardiovascular disease is the leading cause of death in both men and women, accounting for one-third of all deaths. Although several studies have shown an improvement of prognosis in women over time, overall outcomes remain worse for women compared with men, providing a strong rationale for focusing on the study of sex-based differences in the outcome of acute coronary syndromes," according to background information in the article. Previous analyses of the differences in outcomes for men and women following ACS have reported conflicting results. Jeffrey S. Berger, M.D., M.S., of the New York University School of Medicine, New York, and colleagues evaluated the relationship between sex and 30-day mortality following ACS and analyzed factors such as clinical classification at the time of ACS and the severity of angiographic disease. Patients for the study were pooled from a sample of 11 independent, international, randomized ACS clinical trials between 1993 and 2006. Of the 136,247 patients in this analysis, 38,048 (28 percent) were women. There were 102,004 patients (26 percent women) with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack); 14,466 with non-STEMI (NSTEMI; 29 percent women); and 19,777 with unstable angina (40 percent women). Women were older and had a higher prevalence of hypertension, hyperlipidemia, diabetes and heart failure. Men were more likely to be smokers and had a higher prevalence of prior heart attack and prior coronary artery bypass graft surgery. The researchers found that women had a significantly higher unadjusted 30-day risk of death compared with men (9.6 percent vs. 5.3 percent). But after multivariable adjustment for clinical characteristics and clinical presentation, no significant difference was observed in 30-day mortality. "Perhaps the most striking findings in our analyses relate to the examination of mortality according to type of ACS. We found a significant interaction between sex and type of ACS, such that 30-day mortality risk among women was modestly higher than men only for those patients presenting with STEMI. In patients with NSTEMI and unstable angina, women had a lower adjusted 30-day mortality risk than men. In fact, the strongest finding after full adjustment was lower risk among women with unstable angina," the authors write. The researchers also found that overall, women who underwent catheterization were more likely to have nonobstructive coronary artery disease and less likely to have multivessel disease compared with men. The relationship between sex and 30-day mortality was similar across the levels of angiographic disease severity. "Our study suggests a better understanding of the observed sex-based differences. Sex-based differences exist in 30-day mortality among patients with ACS and vary depending on clinical presentation. However, these differences are markedly attenuated following adjustment for clinical differences and angiographic data. The attenuation in the difference in mortality suggests that much of the crude differences are explained by these factors. This study further highlights the clinical and angiographic differences among men and women at presentation with ACS. Understanding and considering these differences may lead to better risk stratification and treatment of all patients with ACS," the researchers conclude. JAMA and Archives Journals |
|||||||||||||||||||||
| Related Coronary Syndrome Current Events and Coronary Syndrome News Articles A consistent decline in heart attack rates following the implementation of smoking bans Strongly enforced legislation to restrict smoking produces rapid and substantial reductions in community rates of heart attack, according to a meta-analysis published today in Circulation, the journal of the American Heart Association. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes Data from a phase II trial of an investigational intravenous drug designed to block the formation of blood clots shows potential to reduce the risk of death, a second heart attack, or other coronary complications compared with the current standard of care in patients presenting with acute coronary syndromes (heart attacks or unstable angina). Study finds women slightly more likely to die than men in the 30 days following a heart attack A new study from NYU School of Medicine found that women may have a slightly higher risk of death than men in the thirty days following an acute coronary syndrome (ACS), but that these differences appear to be attributable to factors such as severity and type of ACS. Emergency physician judgment on chest pain patients syncs with their outcomes Emergency physicians should trust their judgment when evaluating patients who report with chest pain symptoms, said a group of researchers led by Abhinav Chandra, M.D., at Duke University Medical Center. Massive decline in rates of coronary death in Iceland are largely attributed to risk factor reductions in the population In the 25 years between 1981 and 2006 mortality rates from coronary heart disease (CHD) in Iceland decreased by a remarkable 80% in men and women aged between 25 and 74 years. Combination of ASA and clopidogrel reduces heart attack risk in patients with acute coronary syndrome In order to better prevent blood clots, clopidogrel can be prescribed to patients with acute ischaemia of the heart muscle, in addition to acetylsalicylic acid (ASA). The Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated whether the combination of clopidogrel and ASA actually has a higher benefit for patients than ASA alone. Emergency treatment strategies, better communication reduce heart attack patient deaths Four western New York hospitals using emergency treatment strategies emphasizing evidence-based therapy and better communication among health care providers reduced heart attack patient deaths by 19 percent for up to one year after patient discharge. An ESC statement on gender differences in medical care and survival after myocardial infarction A paper published online by the journal Circulation on 8 December 2008 concluded that, while men and women have a similar in-hospital death rate following acute myocardial infarction, women with STEMI had an adjusted mortality rate almost twice as high as men (10.2% versus 5.5%). Double threat: Deadly lung disease also linked to heart attacks Patients with idiopathic pulmonary fibrosis (IPF) are three times as likely to experience severe coronary events-including heart attacks-than people without the disease. Mechanisms of cardiovascular disease and cancer give clues to new therapies Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level. More Coronary Syndrome Current Events and Coronary Syndrome News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||